Literature DB >> 28869935

Fetal Aneuploidy: A Comparison of Dichorionic Twins and Monochorionic Twins.

Xiaomei Shi1, Lin Li, Xuan Huang, Baojiang Chen, Yi Zhou, Qun Fang.   

Abstract

OBJECTIVE: To assess the clinical characteristics of fetal aneuploidy between dichorionic twins (DCT) and monochorionic twins (MCT) undergoing invasive prenatal diagnosis.
METHODS: Twin fetuses undergoing invasive prenatal diagnosis were enrolled in this study. All twin fetuses were classified into 2 groups according to chorionicity. The rates of fetal aneuploidy in different groups were compared. RESULT: This study included 1,714 fetuses (857 sets of twin pairs); among them, 1,190 were DCT and 524 were MCT. Overall, the rate of aneuploidy was 4.7% (56/1,190) in DCT and 3.4% (18/524) in MCT. Sixty-four (86.5%, 64/74) fetal aneuploidies occurred in only one fetus of the twin pairs. In DCT, the most common aneuploidy was trisomy 21 (53.6%, 30/56), followed by trisomy 18 (21.4%, 12/56) and trisomy 13 (8.9%, 5/56), while in MCT, the most common aneuploidy was Turner syndrome (33.3%, 6/18), followed by trisomy 21 (27.7%, 5/18) and 47,XYY (11.0%, 2/18).
CONCLUSION: Aneuploidy mostly occurred in only one fetus in the twin pairs. The most common aneuploidy was trisomy 21 in DCT and Turner syndrome in MCT. Dual amniocentesis should be performed when discordant monozygotic twins are suspected.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Dichorionic twins; Fetal aneuploidy; Monochorionic twins; Zygosity

Mesh:

Year:  2017        PMID: 28869935     DOI: 10.1159/000479685

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  1 in total

1.  Prevalence and outcomes of twin pregnancies in Botswana: a national birth outcomes surveillance study.

Authors:  Arielle Isaacson; Modiegi Diseko; Gloria Mayondi; Judith Mabuta; Sonya Davey; Mompati Mmalane; Joseph Makhema; Denise L Jacobson; Rebecca Luckett; Roger L Shapiro; Rebecca Zash
Journal:  BMJ Open       Date:  2021-10-21       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.